Main Office: 503.224.1371 | Hours: Mon-Fri 8:00 AM - 5:00 PM PST

8Apr, 2019

The Benefits of Wisdom Teeth Removal

By: | Tags:

You may feel apprehensive if your dentist tells you it’s necessary to have your wisdom teeth removed. Although the idea may seem a little scary, wisdom teeth extraction can provide many significant benefits to your oral and overall health–and save you from future pain. Here’s what you need to know about wisdom teeth removal.
READ MORE

3Apr, 2019

Three Things To Consider With Oral Surgery And Diabetes

By: | Tags:

If you’re one of the 30 million Americans with diabetes, you know that the disease can make life a little more complicated. To stay healthy, you have to follow a doctor-prescribed diet, get sufficient exercise, monitor your blood sugar levels–and take special care of your oral health.
READ MORE

Oral-Surgeon-and-Facial-Surgeon-Portland-Oregon-Doctors-Without-Borders-Face-To-Face-Magazine-Melissa-Amundson
4Jan, 2019

Melissa Amundson appeared in Face to Face Magazine

By: | Tags:

Melissa Amundson appeared in Face to Face Magazine We are excited to announce Melissa Amundson’s appearance in Face to Face magazine along with MSF and Noma Surgery in Nigeria. We are very proud of her courage and commitment towards helping those with medical needs, no matter where they’re located! In the article, she explains Medecins Sans Frontieres (MSF)’s mission, in how they provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. MSF is a non-profit, self-governed, member-based organization. It was founded in 1971 by a […]
READ MORE

Dr-Bell-Neoadjuvant-Anti-OX40
7Jun, 2018

Neoadjuvant Anti-OX40 May Prevent Disease Recurrence And Increase Tumor Immunity In Patients With Resectable HNSCC

By: | Tags:

Neoadjuvant Anti-OX40 May Prevent Disease Recurrence And Increase Tumor Immunity In Patients With Resectable HNSCC R. Bryan Bell, MD (Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA) discussed phase 1b clinical trial (NCT02274155) results investigating efficacy of anti-OX40 (MEDI6469) in the neoadjuvant setting for HNSCC resection candidates. In all, 17 patients (resectable stage III-IVA HNSCC, 11 = HPV-, 6 = HPV+) received three anti-OX40 doses (0.4mg/kg) daily on day 0, 2, and 4 of the study, and then underwent resection between 2 days – 2 weeks after […]
READ MORE

7May, 2018

Eric Dierks Hosting Annual Meeting In Portland, OR

By: | Tags:

Annual Meeting at the Hines Hotel Eric Dierks, President and founding member of the American Academy of Cranio-Maxillofacial Surgery, along with HNSA, are hosting the annual meeting in Portland, OR this year at the Nines Hotel! For more information, click here
READ MORE